Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort
Gianmarco Lombardi(University of Verona), Sandra Biribauer, Anke Torp, Nikolaus Frischmuth, Nicholas C Chesnaye(Amsterdam Neuroscience), Hans Schmidt-Gürtler, Christian Marx, Kai Hahn, Justyna Mazur, Ines Schlee, Sabine Aign, Kirsten Anding‐Rost, Katja Blouin, Holger Naujoks, Christoph Wanner(Universitätsklinikum Würzburg), Eva Platen, Marie Evans(Karolinska University Hospital), Monika Hopf, Giovanni Gambaro(University of Verona), Pawlos Ichtiaris, Olof Heimbürger(Karolinska University Hospital), Kitty J. Jager(Amsterdam University Medical Centers), Katrin Neumeier, Christiane Drechsler(Universitätsklinikum Würzburg), Andreas Schneider, Petra Kirste, Sabine Cäsar, Vianda S Stel(Amsterdam UMC Location University of Amsterdam), Petra Schulz, Pietro Manuel Ferraro(Università Cattolica del Sacro Cuore), Boris Perras, Dunja Fuchs, Beate Iwig, Joachim Beige, Nadja Wuttke, Friedo W. Dekker(Leiden University Medical Center), Hendrik Schlee, Fergus Caskey, Claudia Emde, Maria Pippias(North Bristol NHS Trust), Christof Blaser, Detlef H. Krieter(Universitätsklinikum Würzburg), Lothar Schramm, Ellen Irmler, Claudia Torino(National Institute Of Hygiene And Epidemiology), Jochen Röthele
Cited by 2
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927